Oncology Services India (OSI) will offer a complete clinical service range from Phase I (first-in-men) to Phase IV (PMS) trials. The company said that it plans to offer services to offshore clients, apart from Indian clients.
Wolfgang Beier, CEO of Oncology Services Europe (OSE), said: “By extending presence in India, OSE can reap definite benefits of faster recruitment for quality data and cost-effective clinical services for its global clients. Clinical services are now a global opportunity for India with a strong competitive edge based on speed and quality of clinical development.
“OSI will have unlimited access to expertise and technology assistance of our European operations. Our experience of dealing with international clients with diversified needs in terms of clinical services will be an asset to our Indian operations.”